Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins ; volume:5 ; number:1 ; day:26 ; month:9 ; year:2006 ; pages:1-8 ; date:12.2006
Cardiovascular diabetology ; 5, Heft 1 (26.9.2006), 1-8, 12.2006
- Urheber
-
Tenenbaum, Alexander
Fisman, Enrique Z.
Motro, Michael
Adler, Yehuda
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1475-2840-5-20
- URN
-
urn:nbn:de:101:1-2021082521110282824475
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tenenbaum, Alexander
- Fisman, Enrique Z.
- Motro, Michael
- Adler, Yehuda
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Targeting AMPK by Statins: A Potential Therapeutic Approach
Inpatient therapeutic options
Future therapeutic options
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Targeting AMPK by Statins: A Potential Therapeutic Approach
Inpatient therapeutic options
Future therapeutic options
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Targeting AMPK by Statins: A Potential Therapeutic Approach
Inpatient therapeutic options
Future therapeutic options
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation